Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper

Journal of Drugs in Dermatology

Volumn 7, Issue 7, 2008, Pages 643-646

  Krejci Manwaring, Jennifer ^a   McCarty, Martha Ann ^c   Camacho, Fabian ^a   Manuel, Janeen ^a   Hartle, Jennifer ^b   Fleischer Jr , Alan ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b ASTELLAS PHARMA INC   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; TACROLIMUS;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HAND DISEASE; HUMAN; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; AGED; DERMATITIS, ATOPIC; DERMATITIS, CONTACT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HAND DERMATOSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREDNISONE; TACROLIMUS;

EID: 52449093020     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Meding B, Jarvholm B. Hand eczema in Swedish adults - changes in prevalence between 1983 and 1996. J Invest Dermatol. 2002; 118:719-723.
2. Bryld LE, Hindsberger C, Kyvik KO, et al. Risk factors influencing the development of hand eczema in a population-based twin sample. Br J Dermatol. 2003;149:1214-1220. (Pubitemid 38063116)
3. Rystedt I. Hand eczema and long-term prognosis in atopic dermatitis. Acta Derm Venereol (Stockh). 1985;117 (Suppl):159.
4. Christensen OB. Prognosis in nickel allergy and hand eczema. Contact Dermatitis. 1982;8:715.
5. Lammintausta K, Kalimo K. Atopy and hand dermatitis in hospital wet work. Contact Dermatitis. 1981;7:301-308. (Pubitemid 12250408)
6. Rystedt I. Long term follow-up in atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1985;114:117-120. (Pubitemid 15112162)
7. van Coevorden AM, Kamphof WG, van Sonderen E, et al. Comparison of oral psoralen-UVA with a portable tanning unit at home vs hospital-administered bath psoralen-UVA in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy. Arch Dermatol. 2004;140:1463-1466. (Pubitemid 39627437)
8. Sjovall P, Christensen OB. Local and systemic effect of ultraviolet irradiation (UVB and UVA) on human allergic contact dermatitis. Acta Derm Venereol. 1986;66:290-294. (Pubitemid 16048389)
9. Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol. 1996;76:371-376. (Pubitemid 26297982)
10. Alomar A, Puig L, Gallardo CM, Valenzuela N. Topical tacrolimus 0.1% ointment (Protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis. 2003;49:185-188. (Pubitemid 38230763)
11. Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg. 2004;30:130-135. (Pubitemid 38313998)
12. Bergman J, Rico MJ. Tacrolimus: clinical studies for atopic dermatitis and other conditions. Semin Cutan Med Surg. 2001;20:250-259. (Pubitemid 33139092)